Forma Therapeutics

$44.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.48 (-1.08%) As of 1:33 PM EDT today

Why Robinhood?

You can buy or sell FMTX and other stocks, options, and ETFs commission-free!

About FMTX

Forma Therapeutics Holdings, Inc. Common Stock, also called Forma Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Read More Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. The listed name for FMTX is Forma Therapeutics Holdings, Inc. Common Stock.

CEO
Frank D. Lee
Employees
Headquarters
Watertown, Massachusetts
Founded
2011
Market Cap
1.81B
Price-Earnings Ratio
Dividend Yield
Average Volume
121.99K
High Today
$44.54
Low Today
$42.53
Open Price
$44.19
Volume
56.07K
52 Week High
$52.75
52 Week Low
$31.45

Collections

FMTX Earnings

-$4.58
-$3.05
-$1.53
$0.00
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, Pre-Market

You May Also Like